The one thing to understand first: they're different molecules
The confusing part is the naming. "Melanotan" refers to a family of lab-made peptides based on α-MSH, the body's natural pigmentation hormone. Within that family, Melanotan I and Melanotan II are distinct compounds with different structures and, crucially, different receptor selectivity — which is what drives everything else about how they behave.
Melanotan I is fairly selective: it mainly activates MC1R, the receptor on pigment cells that controls skin darkening. Melanotan II is non-selective: it hits MC1R and MC4R (which affects appetite and sexual response) plus a couple of others. That single difference explains why MT-I stays in its lane (pigmentation) while MT-II produces a much broader — and messier — set of effects.
Melanotan I
Afamelanotide • brand name Scenesse
- 13-amino-acid analog of α-MSH
- Mostly selective for MC1R (pigmentation)
- FDA-approved (2019) for a rare disease
- Given as a physician-placed implant every ~2 months
- Quality-controlled, monitored, prescription-only
- Not available for cosmetic tanning
Melanotan II
"MT-2" • unregulated tanning peptide
- Cyclic heptapeptide; broader structure
- Non-selective (MC1R + MC4R + others)
- Not FDA-approved; multiple agency warnings
- Self-injected subcutaneously, sourced online
- No identity or purity control
- Used for tanning and sexual-response effects
Is one the "original"? And which is more popular?
Melanotan I came first — it's the earlier analog. Both peptides trace back to the same melanocortin research program at the University of Arizona in the 1980s. Melanotan I (afamelanotide) is the earlier, simpler linear molecule. Melanotan II was engineered afterward as a more compact, cyclic version, deliberately designed to be more potent and longer-lasting — early papers called it "superpotent." So if you're picturing MT-I as the original and MT-II as the souped-up follow-up, that's a fair way to think about it.
But Melanotan II is overwhelmingly the more popular one. When someone says "melanotan," they almost always mean MT-II — it's the potent, self-injectable compound that the cosmetic-tanning community actually uses, and it's what the vast majority of online searches and products refer to. Melanotan I, by contrast, is famous only in a narrow medical lane: it's the approved drug Scenesse for a rare disease, and most people have never heard of it under the name "afamelanotide." So the older molecule (MT-I) is the legitimate-but-obscure one, and the newer, more potent molecule (MT-II) is the popular-but-unregulated one.
At a glance
| Parameter |
Melanotan I (Scenesse) |
Melanotan II |
| Full name |
Afamelanotide |
Melanotan II (no approved drug name) |
| Receptor selectivity |
Mostly MC1R (selective) |
MC1R + MC4R + MC3R/MC5R (non-selective) |
| FDA status |
Approved 2019 for erythropoietic protoporphyria (EPP) |
Not approved; consumer warnings issued |
| How it's taken |
Dissolvable implant placed by a physician (~every 2 months) |
Self-administered subcutaneous injection |
| Main real-world use |
Photoprotection in a rare light-sensitivity disease |
Cosmetic tanning; informal sexual-response use |
| Tanning / pigmentation |
Strong pigmentation effect (medically, for photoprotection) |
Strong, potent pigmentation — the one used for cosmetic tanning |
| Sexual-response effect |
Minimal (selective receptor profile) |
Yes (via MC4R) — led to the drug PT-141 |
| Appetite effect |
Minimal |
Can suppress appetite (MC4R) |
| Product quality control |
Pharmaceutical-grade, regulated manufacturer |
None; online products vary in identity/purity |
| Notable safety concerns |
Monitored; darkening of moles/freckles; implant-site effects |
Priapism, melanoma case reports, nausea, BP spikes, kidney injury |
| Approved relative |
PT-141 / bremelanotide (Vyleesi) is the FDA-approved descendant for the sexual-desire use case |
Which one is more effective at tanning?
In practical terms, Melanotan II is the tanning compound. It's a potent, non-selective melanocortin agonist — early research literally described it as "superpotent" — and it's what the entire cosmetic-tanning community uses. If the question is "which one do people actually use to get darker," the answer is unambiguously MT-II.
Here's the nuance, though: Melanotan I also produces robust pigmentation — that's the whole reason it's an approved drug. The difference isn't that MT-I "doesn't tan." It's that MT-I is only available as a controlled medical implant for a specific disease, so you can't obtain it for cosmetic use, and it's dosed for photoprotection rather than for a deep cosmetic tan. So: MT-II wins on cosmetic-tanning potency and accessibility, but that accessibility is exactly what makes it dangerous — it's unregulated and self-injected, with none of the safety monitoring that comes with the approved compound.
Verdict — tanning
Melanotan II is more potent for cosmetic tanning and is the one people use for it — but "more effective at tanning" and "safe to use" are not the same thing, and MT-II is the far riskier compound.
Which one is better for everything else?
Sexual-response effects: this comes from MC4R activation, which is Melanotan II's territory, not Melanotan I's. MT-II users have long reported libido and erection effects — and that observation is what led researchers to develop PT-141 (bremelanotide), which is FDA-approved for low sexual desire in premenopausal women. So if the interest is the sexual-response angle, the honest answer is that neither Melanotan is the right tool: the regulated, studied option is PT-141.
A real medical use: only Melanotan I has one. As Scenesse, it's approved to help people with erythropoietic protoporphyria (EPP) — a rare genetic condition that makes sunlight intensely painful — tolerate light exposure by boosting protective pigment. That's a genuine, evidence-backed benefit, but it's specific to that disease and only accessible by prescription.
Appetite: MT-II's MC4R activity can blunt appetite, but this isn't a developed or recommended use, and it's not a reason to choose it.
Verdict — other effects
Melanotan I is the only one with a legitimate approved medical use (EPP photoprotection). For sexual-response effects, the better-studied, regulated choice is PT-141 — not either Melanotan.
Side effects: how they compare
This is where the two really diverge, and it's mostly down to that selective-vs-non-selective difference.
Melanotan I (Scenesse) has a comparatively contained side-effect profile. Because it's selective and delivered under medical supervision, the common issues are things like darkening of existing moles and freckles, occasional nausea or headache, and implant-site reactions. Patients are monitored, and dermatologic surveillance is part of the approved protocol. It went through clinical development, so its risks are characterized.
Melanotan II has a much longer and more serious list, precisely because it activates so many receptors and is used without oversight: priapism (a urological emergency), case reports of new or changing melanomas, severe nausea, flushing, blood-pressure fluctuations, and even kidney injury and rhabdomyolysis in the case literature. On top of the biology, the products themselves are unregulated, so purity and identity are inconsistent. This is why multiple national health agencies have issued warnings.
Verdict — safety
Melanotan I is clearly the safer of the two: it's regulated, monitored, and has a characterized risk profile. Melanotan II's documented adverse events are serious and its supply is uncontrolled.
So why would someone choose one over the other?
Someone "chooses" Melanotan I only in a medical context. You don't pick Scenesse for cosmetic reasons — you receive it because you have EPP and a specialist prescribes it. It's regulated, quality-controlled, and administered by a clinician. There's no version of "getting MT-I for a tan"; it isn't sold that way.
People reach for Melanotan II because it's potent and easy to get. It produces a strong cosmetic tan, it's sold online, and it self-administers with a small injection. Those are the reasons it's popular — and none of them are safety reasons. The accessibility that makes MT-II attractive is the same thing that makes it risky: no oversight, no quality control, and a documented list of serious adverse events.
If the underlying goal is a sunless tan, the honest framing is that neither of these is a "safe tan in a vial." If the goal is the sexual-response effect, the regulated descendant PT-141 exists for a reason. This site covers Melanotan II because people search for it, not because the use case is supported.
The honest read
What's solid:
These are genuinely different molecules. Melanotan I is FDA-approved (as Scenesse) for EPP and has a real, evidence-backed medical use. Melanotan II is a potent tanning agent, and the melanocortin biology behind both is well understood.
What's still being worked out:
Whether the melanoma case reports in MT-II users reflect a causal link or an already-higher-risk population, and what long-term MT-II use does — questions that stay open because no clinical-development program ever finished for it.
What's hyped beyond the evidence:
Treating MT-I and MT-II as two flavors of the same "tanning drug," and framing MT-II as a "safe sunless tan." One is a regulated medicine for a rare disease; the other is an unregulated compound that multiple governments have warned against. The comparison is useful for understanding them — not for treating them as equivalent options.
What people often ask
Are Melanotan I and Melanotan II the same thing?
No. They're separate peptides in the same family. Melanotan I (afamelanotide / Scenesse) is selective and FDA-approved for a rare disease. Melanotan II is non-selective, not approved, and is the one associated with cosmetic tanning and safety warnings.
Which one tans better?
Melanotan II is the more potent cosmetic tanning compound and the one people actually use for tanning. Melanotan I also darkens skin, but it's only available as a medical implant for erythropoietic protoporphyria, not for cosmetic use.
Which is safer?
Melanotan I, clearly. It's regulated, monitored, and has a characterized safety profile. Melanotan II has documented serious adverse events (including priapism and melanoma case reports) and comes from an unregulated supply.
Can I get Melanotan I for a tan?
No. Melanotan I is approved only as Scenesse, a physician-placed implant for people with EPP. It isn't sold or prescribed for cosmetic tanning.
What about the sexual-response effects I've read about?
That's Melanotan II (via MC4R), not Melanotan I. It's also what led to the development of PT-141 (bremelanotide / Vyleesi), the FDA-approved option for low sexual desire in premenopausal women. PT-141 has its own page on this site.
Is either of them legal?
Melanotan I is a legal, approved prescription drug for its specific indication. Melanotan II is not FDA-approved, and selling it for human use is illegal in many countries; "research only" labels are how vendors work around that, not a sign of safety.
FDA and regulatory status
Status as of July 14, 2026: Melanotan I (afamelanotide / Scenesse) is FDA-approved (2019) for adults with erythropoietic protoporphyria; it was approved by the EMA in 2014 for the same indication and is manufactured by Clinuvel Pharmaceuticals. Melanotan II is not FDA-approved for any indication, and the FDA, UK MHRA, Australia's TGA, and Norway's medicines agency have issued consumer warnings against it. The related compound bremelanotide (PT-141 / Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Status updates land here when they happen.